• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSPHERE MEDICAL, S.A. EMBOSPHERE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSPHERE MEDICAL, S.A. EMBOSPHERE; DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION Back to Search Results
Catalog Number S210GH/C
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Reaction to Medicinal Component of Device (4574)
Date of Event 09/09/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
This event was identified during internal quality system activities.Upon review, the manufacturer determined the event meets fda criteria for reporting.The report is being submitted to ensure accuracy and completeness of mdr files.This submission does not reflect a change in device performance or patient risk.The awareness date corresponds to when the manufacturer became aware of the event details.All information reasonably known to the manufacturer at this time has been included.The suspect device was not returned for evaluation.The complaint could not be confirmed.The root cause could not be determined.This complaint will be used to trend for similar complaints.A search of the complaint database was performed and no similar complaints for this lot number were found.The device history record was reviewed, and no exception documents were found.
 
Event or Problem Description
The customer reports the patient experienced hives at the site of treatment after a genicular artery embolization (gae) procedure.The hives subsided with administration of benadryl.The device has been discarded.No additional information was provided.
 
Event or Problem Description
The customer report additional information of: there is no changes in their practice that they can attribute to the reaction.They are high volume gae clinics and they have not changed their contrast agent, catheters used etc.They mix the embosphere according to ifu, and do not add any other agents to the mix.The hives were localized to the treatment (knee from gae procedure) area and were visible post procedure, for approximately an hour.Benadryl was given which resolved the hives/rash.
 
Additional Manufacturer Narrative
Additional information added to b5.Added h4 device manufacture date.Corrections: h3 corrected from yes to no.H6 corrected b code from 4115 to 4114.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOSPHERE
Common Device Name
DEVICE, VASCULAR, FOR PROMOTING EMBOLIZATION
Manufacturer (Section D)
BIOSPHERE MEDICAL, S.A.
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france 95700
FR  95700
Manufacturer (Section G)
BIOSPHERE MEDICAL SA
parc des nations-paris nord 2
383 rue de la belle etole
roissy-en-france 95700
FR   95700
Manufacturer Contact
marie-laure patucca
parc des nations paris nord 2
383 rue de la belle etoile
roissy-en-france 95700
FR   95700
MDR Report Key24845489
Report Number9615728-2026-00065
Device Sequence Number8947043
Product Code KRD
UDI-Device Identifier00884450403174
UDI-Public00884450403174
Combination Product (Y/N)N
Initial Reporter StateNJ
Initial Reporter CountryUS
PMA/510(K) Number
K181300
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/16/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberS210GH/C
Device Lot NumberX3197026-5
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 09/26/2025
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date04/10/2026
Supplement Report FDA Received Date06/16/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured05/05/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-